299 related articles for article (PubMed ID: 26269176)
21. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
[TBL] [Abstract][Full Text] [Related]
22. A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71.
Wang X; Peng W; Ren J; Hu Z; Xu J; Lou Z; Li X; Yin W; Shen X; Porta C; Walter TS; Evans G; Axford D; Owen R; Rowlands DJ; Wang J; Stuart DI; Fry EE; Rao Z
Nat Struct Mol Biol; 2012 Mar; 19(4):424-9. PubMed ID: 22388738
[TBL] [Abstract][Full Text] [Related]
23. Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16.
He M; Xu L; Zheng Q; Zhu R; Yin Z; Zha Z; Lin Y; Yang L; Huang Y; Ye X; Li S; Hou W; Wu Y; Han J; Liu D; Li Z; Chen Z; Yu H; Que Y; Wang Y; Yan X; Zhang J; Gu Y; Zhou ZH; Cheng T; Li S; Xia N
Cell Host Microbe; 2020 Feb; 27(2):249-261.e5. PubMed ID: 32027857
[TBL] [Abstract][Full Text] [Related]
24. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
Tsou YL; Lin YW; Shao HY; Yu SL; Wu SR; Lin HY; Liu CC; Huang C; Chong P; Chow YH
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003692. PubMed ID: 25855976
[TBL] [Abstract][Full Text] [Related]
25. Human enterovirus 71 uncoating captured at atomic resolution.
Lyu K; Ding J; Han JF; Zhang Y; Wu XY; He YL; Qin CF; Chen R
J Virol; 2014 Mar; 88(6):3114-26. PubMed ID: 24352461
[TBL] [Abstract][Full Text] [Related]
26. Analysis and solution of false-positives when testing CVA16 sera using an antibody assay against the EV71 virus.
Wang C; You A; Tian X; Zhao M; Chen Y; Lin T; Zheng J; Xiao M; Zhang Y; Kuang L; Zhou Z; Zhu B
Virus Res; 2013 Sep; 176(1-2):33-6. PubMed ID: 23707400
[TBL] [Abstract][Full Text] [Related]
27. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N
Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182
[TBL] [Abstract][Full Text] [Related]
28. Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.
Zhao H; Li HY; Han JF; Deng YQ; Zhu SY; Li XF; Yang HQ; Li YX; Zhang Y; Qin ED; Chen R; Qin CF
Sci Rep; 2015 Jan; 5():7878. PubMed ID: 25597595
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies for diagnosis of enterovirus 71.
Xu L; Huang KJ; Ho TS; Liu CC; Lee YR; Lin CY; Shiuan D; Jiang XH
Monoclon Antib Immunodiagn Immunother; 2013 Dec; 32(6):386-94. PubMed ID: 24328741
[TBL] [Abstract][Full Text] [Related]
30. Characterization of enterovirus 71 and coxsackievirus A16 isolated in hand, foot, and mouth disease patients in Guangdong, 2010.
He SJ; Han JF; Ding XX; Wang YD; Qin CF
Int J Infect Dis; 2013 Nov; 17(11):e1025-30. PubMed ID: 23791223
[TBL] [Abstract][Full Text] [Related]
31. Structural Basis for Recognition of Human Enterovirus 71 by a Bivalent Broadly Neutralizing Monoclonal Antibody.
Ye X; Fan C; Ku Z; Zuo T; Kong L; Zhang C; Shi J; Liu Q; Chen T; Zhang Y; Jiang W; Zhang L; Huang Z; Cong Y
PLoS Pathog; 2016 Mar; 12(3):e1005454. PubMed ID: 26938634
[TBL] [Abstract][Full Text] [Related]
32. Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.
Liu CC; Guo MS; Wu SR; Lin HY; Yang YT; Liu WC; Chow YH; Shieh DB; Wang JR; Chong P
Antiviral Res; 2016 May; 129():58-66. PubMed ID: 26899790
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of a cross-neutralization epitope of Enterovirus 71.
Liu CC; Chou AH; Lien SP; Lin HY; Liu SJ; Chang JY; Guo MS; Chow YH; Yang WS; Chang KH; Sia C; Chong P
Vaccine; 2011 Jun; 29(26):4362-72. PubMed ID: 21501643
[TBL] [Abstract][Full Text] [Related]
34. The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus.
Wu CY; Yu SL; Chen YT; Chen YH; Hsiao PW; Chow YH; Chen JR
PLoS One; 2019; 14(1):e0210553. PubMed ID: 30650163
[TBL] [Abstract][Full Text] [Related]
35. Potential of a bivalent vaccine for broad protection against enterovirus 71 and coxsackie virus 16 infections causing hand, foot, and mouth disease.
Yi EJ; Kim YI; Song JH; Ko HJ; Ahn SH; Lee HJ; Suh B; Yu J; Park J; Lee YJ; Jung EJ; Chang SY
Vaccine; 2023 Sep; 41(41):6055-6063. PubMed ID: 37648607
[TBL] [Abstract][Full Text] [Related]
36. Identification and production of mouse scFv to specific epitope of enterovirus-71 virion protein-2 (VP2).
Thanongsaksrikul J; Srimanote P; Tongtawe P; Glab-Ampai K; Malik AA; Supasorn O; Chiawwit P; Poovorawan Y; Chaicumpa W
Arch Virol; 2018 May; 163(5):1141-1152. PubMed ID: 29356992
[TBL] [Abstract][Full Text] [Related]
37. A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice.
Wang X; Ku Z; Dai W; Chen T; Ye X; Zhang C; Zhang Y; Liu Q; Jin X; Huang Z
Vaccine; 2015 Oct; 33(43):5779-5785. PubMed ID: 26424606
[TBL] [Abstract][Full Text] [Related]
38. Determinants of EV71 immunogenicity and protection against lethal challenge in a mouse model.
Chang J; Li J; Wei W; Liu X; Liu G; Yang J; Zhang W; Yu XF
Immunol Res; 2015 Jul; 62(3):306-15. PubMed ID: 26025091
[TBL] [Abstract][Full Text] [Related]
39. Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo.
Yao X; Mao Q; Li Y; Hao C; Bian L; Chen P; Gao F; Wu X; Lu W; Gao Q; Li X; Liang Z
Hum Vaccin Immunother; 2018 May; 14(5):1275-1282. PubMed ID: 29337652
[TBL] [Abstract][Full Text] [Related]
40. Production of EV71 vaccine candidates.
Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
